Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia
在伴有高胆红素血症的肝细胞癌患者中,IL-17A 水平升高与免疫检查点抑制剂联合靶向治疗后总体生存率降低相关。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1791538
Wang, Jianing; Pan, Shida; Xiong, Chuyue; Tian, Jiahe; Wang, Yilin; Yu, Yingying; Wang, Siyu; Shen, Yingjuan; Yang, Luo; Liu, Xiaomeng; Luan, Junqing; Jia, Mengdie; Duan, Xuanxuan; Wang, Fusheng; Meng, Fanping
肿瘤
肿瘤免疫
IL-17
IL-17A
细胞生物学
免疫/内分泌